Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB123667 Food Effect and DDI Study in Healthy Participants
NCT06909162Phase 1Completed
- Sponsor
- Incyte
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of INCB123667 (4 cohorts), sponsored by Incyte. Primary endpoints: Maximum Observed Plasma Concentration, Time to Maximum Plasma Concentration and 2 more. Started May 2025; status: completed.
02
Drugs
INCB123667
Beyond the preview
Go deeper on NCT06909162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06909162.